Total Funding
75
64
Total FundingFunding Round raised
Growth Score 75 in past quarter
-6 pts
Heat Score 64 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17422
Maxwell Biosciences is biotechnology for optimizing cognitive performance and health span.
Joshua McClure: CEO & FounderPast Role: RealMassive, Founding CEO- Beth Burnside: Sr. Vice President of R&D Strategy
About the Company
Maxwell Biosciences is a preclinical-stage drug platform company actively developing an entirely new CLAROMER biotechnology platform that creates low-molecular-weight compounds that mimic antimicrobial peptides and are functionally distinct from macromolecules due to their ease of penetrating membranes.
